Unknown

Dataset Information

Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer.


ABSTRACT:

Background

The tumorigenesis of prostate cancer involves genetic mutations. Tumour mutational burden (TMB) is an emerging biomarker for predicting the efficacy of immunotherapy.

Results

Single-nucleotide polymorphisms were the most common variant type, and C>T transversion was the most commonly presented type of single-nucleotide variant. The high-TMB group had lower overall survival (OS) than the low-TMB group. TMB was associated with age, T stage and N stage. Functional enrichment analysis of differentially expressed genes (DEGs) showed that they are involved in pathways related to the terms spindle, chromosomal region, nuclear division, chromosome segregation, cell cycle, oocyte meiosis and other terms associated with DNA mutation and cell proliferation. Six hub genes, PL

SUBMITTER: Wang L 

PROVIDER: S-EPMC7905899 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature